Answers are grounded in this paper and cite their sources.
In a biracial community-based sample of adults, we observed that sex differences, CKD, and vascular risk factors, but not self-reported race, contributed to variation in plasma AD biomarkers. Although some prior studies have reported primary effects of race/ethnicity, our results reinforce the need to account for broad-based medical and social determinants of health (including sex, systemic comorbidities, and other factors) in effectively and equitably deploying plasma AD biomarkers in the general population.
No takes yet. Share an insight, caveat, or question.
Ramanan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: